RecruitingPhase 2NCT07511725
Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma
Studying Giant cell glioblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Intervention
- Maximal surgical resection(procedure)
- Enrollment
- 38 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2026 – 2029
Study locations (1)
- 2nd Affiliated Hospital, School of Medicine, Hangzhou, Zhejiang, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07511725 on ClinicalTrials.govOther trials for Giant cell glioblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07544992Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade GliomasCity of Hope Medical Center
- RECRUITINGEARLY PHASE1NCT07268053A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain MetastasesNader Sanai
- RECRUITINGPHASE3NCT07195591Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CareGT Medical Technologies, Inc.
- RECRUITINGPHASE2NCT07263438Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 TrialCentre Hospitalier Universitaire Vaudois
- RECRUITINGPHASE1NCT06176066PH Sensitive MRI Based Resections of GlioblastomaUniversity of California, Los Angeles
- RECRUITINGNANCT07121842Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRIErasmus Medical Center
- RECRUITINGNANCT06136611Preoperative Preradiotherapy TTFieldsThe Christie NHS Foundation Trust
- RECRUITINGNANCT06001281Predictive Value of Soluble CD146 in Glioblastoma PatientsAssistance Publique Hopitaux De Marseille